Meta-Analysis of Structured Triglyceride versus Physical Mixture Medium- and Long-Chain Triglycerides for PN in Liver Resection Patients

Table 1

The characteristics of all the included studies.

Author	Year	Country	Study type	Group	Patients number	Male/female	Age,	Study quality; RCT (Jadad system); Retro (NOS system)
Peng et al. [5]	2017	China	RCT	STG	50	33/17	52.1 ± 8.5	7
				MCT/LCT	50	30/20	51.3 ± 3.2
Shi et al. [6]	2015	China	RCT	STG	40	25/15	56 ± 10	5
				MCT/LCT	40	26/14	57 ± 11
Wu et al. [7]	2013	China	RCT	STG	33	25/8	49.1 ± 1.8	7
				MCT/LCT	33	25/8	51.3 ± 3.2
Zhou et al. [8]	2011	China	RCT	STG	29	24/5	53.83 ± 10.29	7
				MCT/LCT	30	23/7	52.37 ± 12.27
Jing et al. [9]	2010	China	RCT	STG	64	47/17	49.9 ± 8.6	5
				MCT/LCT	61	45/16	48.7 ± 10.5
Zhuo and Qi [10]	2010	China	RCT	STG	43	25/18	43.0 ± 5.0	7
				MCT/LCT	43	27/16	45.0 ± 8.0

RCT = randomized controlled trial; STG: structured triglycerides; MCT/LCT: medium- and long-chain triglycerides.